May 17, 2022
May 17, 2022
Categories

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

Do you like it?
Read more
April 11, 2022
April 11, 2022
Categories

As NCI-MATCH winds down, cancer research community takes stock of lessons learned

Do you like it?
Read more
March 17, 2022
March 17, 2022
Categories

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
March 1, 2022
March 1, 2022
Categories

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

Do you like it?
Read more
April 26, 2021
April 26, 2021
Categories

Press Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers

Do you like it?
Read more
October 13, 2020
October 13, 2020
Categories

Press Release: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

Do you like it?
Read more
January 7, 2020
January 7, 2020
Categories

Press Release: NCI-MATCH finds that T-DM1 shows promising activity in salivary gland cancer

Do you like it?
Read more
December 19, 2019
December 19, 2019
Categories

Press Release: NCI-MATCH finds promising signal for nivolumab beyond colorectal cancer

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group